High Cost of Uk Gasoline Prices Fuels Debate
Revance's Botox Rival Receives USFDA Nod
By Indu Tyagi Ketan , 19 October, 2022
DaxibotulinumtoxinA (Daxxify), Revance's long-awaited Botox rival, has officially received FDA approval, as the company is now gearing up to establish its brand. Daxxify is an intravenous neuromodulator similar to Botox; its novel peptide exchange technology temporarily eases the moderate to severe glabellar (frown) lines.
The trials revealed that a single injection had a significant anti-wrinkle impact on durational effects were proven in phase 3 trials with 4,200 treatments and 2,700 patients. The chief differentiator for Daxxify is its endurance; it can last six months and has even proven effective for up to nine months in some individuals, vis-a-vis Botox injections that last only for three months.
Daxxify was initially scheduled to receive FDA approval in November 2020, but the epidemic slowed inspection. After visiting Revance's production facility, inspectors discovered quality control and record-keeping issues. The FDA then issued Revance a detailed response letter in October of last year. Soon after, the FDA approved the changes in July after Revance resolved all five problems mentioned in the Complete Response Letter.
In a separate report, Goldman Sachs predicted that Revance's Daxxify will cost about 30% more than its competitors, even though pricing has not yet been made public. This cost considers the extended value proposition for both doctors and patients. Revance's stock rose 18% in September post the FDA's approval, which is expected to end Botox's long-standing dominance in the aesthetics industry.
FDA Approves DaxibotulinumtoxinA (Daxxify)
Latest News
High Cost of Uk Gasoline Prices Fuels Debate
Asia's Leadership in Global Oil Imports: Consequences for the Automotive Sector in 2025
Asia has retained the position as the top oil importer in 2025, and continues to maintain that critical position in the energy sector that the world relies on. China has retained its top spot as the most prominent crude oil importer since 2013. The…
Tesla’s 2025 Crisis: Why Europe is Turning its Back on Elon Musk’s EV Empire
Once the clear leader in the electric vehicle (EV) sector, Tesla's European market is expected to be drastically declining in 2025. Although CEO Elon Musk is still divisive in the United States, recent registration numbers show a bleak image of…
Brits Support Recycling Tax to Address Waste Crisis, but Issues about Fairness Loom
In 2025, the UK government unveiled many essential policies to address the growing trash situation, including a new plastic packaging tax and a landfill fee rise to lessen dependency on landfills. Studies show that over half of Britons support taxes…
China’s Growing Nuclear Energy Development in 2025- A Game Changer for Global Energy
Nuclear energy capacity is growing significantly from the beginning of 2025. It is due to increasing concerns over climate change, and energy security amidst fluctuating fuel prices followed by net-zero targets set up by nations globally. Further…
Indu Tyagi Ketan
Chief Strategy Officer
Latest News
Asia's Leadership in Global Oil Imports: Consequences for the Automotive Sector in 2025
Tesla’s 2025 Crisis: Why Europe is Turning its Back on Elon Musk’s EV Empire
Brits Support Recycling Tax to Address Waste Crisis, but Issues about Fairness Loom
China’s Growing Nuclear Energy Development in 2025- A Game Changer for Global Energy
